Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on December 3, 2004
Molecular Human Reproduction 2005 11(2):117-127; doi:10.1093/molehr/gah135
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
11/2/117    most recent
gah135v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bashamboo, A.
Right arrow Articles by Ali, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashamboo, A.
Right arrow Articles by Ali, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction vol. 11 no. 2 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Fate of SRY, PABY, DYS1, DYZ3 and DYZ1 loci in Indian patients harbouring sex chromosomal anomalies

Anu Bashamboo1, Mohammed Mahidur Rahman1, Aparna Prasad1, Sebastian Padinjarel Chandy1, Jamal Ahmad2 and Sher Ali1,3

1Molecular Genetics Laboratory, National Institute of Immunology, New Delhi-100 067, and 2JN Medical College, Aligarh Muslim University, Aligarh-202 002, India

3 To whom correspondence should be addressed. Email: sheralib5{at}hotmail.com or Email: sherali{at}nii.res.in


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
We analysed chromosomes, conducted hormonal assays and screened genomic DNA of 34 patients with or without detectable Y chromosome for the presence/absence of SRY, PABY, DYS1, DYZ3 and DYZ1 loci and for mutations in the SRY gene. The samples studied represented cases of oligozoospermia, cryptorchidism, Swyer syndrome, Turner syndrome, male pseudohermaphroditism, XXY female syndrome, Klinefelter's syndrome, repeated abortion and instances of male infertility. Chromosomal constitutions and the level of hormones (FSH, LH, PRL, E2 and TSH) were found to be abnormal in several cases. A phenotypic female (P20) positive for all the Y-linked loci screened, showed mutations upstream of the HMG box in the SRY gene. In addition, one or more of the Y-linked loci were detected in several phenotypic females. Fluorescence in-situ hybridization of metaphase chromosomes and interphase nuclei of an aborted fetus with DYZ1 probe detected signals from normal to low levels to its complete absence confirming a complex Y chromosome mosaicism. Upon DNA analysis, the fetus was found to be positive for all the above-mentioned Y-linked loci. Organizational variation within the DYZ1 arrays and its correlation with recurrent spontaneous abortion may be followed-up in subsequent studies to substantiate this observation. This would augment genetic counselling to the affected couples. Prospects of this approach in the overall management of clinical cases with sex chromosome-related anomalies are discussed.

Key words: indels/oligozoospermia/SRY gene/Turner syndrome/Y-linked loci


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The human Y chromosome is reported to have about 76 protein coding genes, though only 27 distinct proteins have been identified thus far (Page, 2004Go). Some of these genes are envisaged to be involved in the control and regulation of spermatogenesis (Lahn and Page, 1997Go; Skaletsky et al., 2003Go). Earlier thought to be a genetic wasteland, the Y chromosome is now found to have expanded its repertoire during the course of evolution by sequence amplification and selectively importing genes from autosomes and X chromosomes (Saxena et al., 1996Go; Skaletsky et al., 2003Go). Contrary to earlier belief, the Y chromosome was found to have gene-rich palindromes of unprecedented magnitude (Kuroda-Kawaguchi et al., 2001Go; Skaletsky et al., 2003Go). Despite gene conversion and palindromic arrangement of the sequences maintaining structural integrity of the Y chromosome, organizational and/or numerical changes leading to sex chromosome anomalies are often encountered. These changes include XY gonadal dysgenesis (Swyer syndrome), XYY males, recurrent spontaneous abortions (RSA), Klinefelter's syndrome and Turner syndrome (TS). The patients with XY female type of gonadal dysgenesis (Swyer syndrome) appearing normal at birth fail to develop secondary sexual characters at puberty, have ‘streak gonads’ and are unable to menstruate. Small deletions in the short arm of the Y chromosome resulting in 46,XY females have been reported (Disteche et al., 1986Go). The other type of XY female gonadal dysgenesis is also caused due to mutation in the Y chromosome (Berta et al., 1990Go; Jager et al., 1990Go). The XYY syndrome, estimated to occur once in a thousand live births is correlated with tall stature, dull intelligence, delayed speech and some learning problems (Fryns et al., 1995Go). Similarly, in case of TS, with 45,XO chromosome constitution occurring in the range 1:2000 to 1:5000 female live births (Hook and Warburton, 1983Go), over 90% of the pure XO conceptuses are eliminated during early prenatal development. After birth, chromosomal mosaicism involving both the X and the Y chromosomes have been reported. The commonly encountered TS karyotypes include 45,X; isochromosome X; 45,X/45,XX; 45,X/46,XY; 45,Xi(Xq); 46,Xi(Yp); 46,Xt(X;X); 46,Xi(X;Y); 46,Xi(Xp); 46,X,del(Xq) r(X); 46,Xr(X) (including small ring X chromosome); 45,/X/46,XX; 45,X/47,XXX; 46,X/46,XX/47,XXX; 45,X/46,XY; and 45,X/46,XXq+46,X+mar(X); 47,XXq+, + mar(X); 46,X+mar(Y); 47,XXq+, + mar(Y) (Ogata and Matsuo, 1995Go). Based on chromosomal imbalance, genomic imprinting and haploinsufficiency, attempts have been made to explain the genetic basis of the TS phenotype (Ogata and Matsuo, 1995Go) involving loci in the pseudoautosomal regions on the short arms of the X and Y chromosomes (Ogata et al., 1995Go; Joseph et al., 1996Go; Schwinger et al., 1996Go). However, the number and type of genes likely to be responsible for TS phenotype remain unclear. The only TS feature present consistently in patients with small distal Xp deletions is their short stature, suggesting that the loci responsible for other features lie outside the pseudoautosomal region (Spranger et al., 1997Go). During the process of developing a physical map of the human Y chromosome, a total of 758 DNA markers were identified of which 136 were found to have multiple locations in the non-recombining regions of the Y chromosome (Tilford et al., 2001Go). Ideally, these markers may be checked in a clinical setting to uncover their possible involvement with abnormal phenotypes. However, logistic constraints may not allow such analysis during routine screening of the patients' DNA samples. We analysed genomic DNA of 34 patients with or without cytogenetically detectable Y chromosome for the presence/absence of DYZ1, DYS1, DYZ3, PABY and SRY loci encompassing both the arms, and conducted chromosomal analyses and hormonal assay. Several phenotypic females were found to harbour one or more of the Y-linked loci and showed multiple point mutation(s). This work broadens our understanding of the mutational profile of the Y-linked loci, leading to more accurate DNA diagnosis and augmenting genetic counselling to the affected couples.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Collection of blood samples and genomic DNA isolation
Blood samples were collected with informed consent from normal males, females, patients and donors/volunteers from J.N. Medical College, Aligarh, India, strictly in accordance with the institute's ethical and biosafety committee. Collection of these samples spanned a period of about 9 years. Genomic DNA from a total of 34 patients together with normal males was isolated following standard protocols (Ali et al., 1986Go). Of these samples, 19 (P2A/2, P2B/14, P2C/16, P3, P4, P5, P6, P7, P8, P9, P10, P11, P15, P65971, P65972, P65975, P6697, P17698, PHK-459) represented TS, three (P18, P20, PR-137) Swyer syndrome, six (P1, P13, P65973, P65974, P7797, P060600) cryptorchidism and hypogonadism, two (P060500MS, P250500) RSA and one each of Klinefelter's syndrome (P19), male pseudohermaphroditism (P12), oligozoospermia (P60199bl) and XXY female syndrome (P21).

Primers and probe for PCR amplification of genomic DNA and hybridization
A set of oligoprimers representing four different loci (PABY, SRY, DYZ3 and DYS1) of the Y chromosome encompassing both the arms were used for PCR amplifications following standard protocols (Bashamboo et al., 2003Go). For the SRY locus, two sets of primers were selected. RG4 and RG7 primers specific to a 231-base pair band were used for typing all the samples. The other set of primers encompassing the HMG box, which generated a 612 base pair fragment, was used for analysing the DNA from the phenotypic female(s) positive for all the five Y-linked loci. The details of the probe and PCR primers, their annealing temperatures, size of the expected amplicons and corresponding references are given in Table I.


View this table:
[in this window]
[in a new window]
 
Table I. Y chromosome-related PCR primers and hybridization probes used for assessing different loci

 
Restriction digestion, agarose gel electrophoresis and Southern blot hybridization
Approximately 0.5 µg of genomic DNA was digested with HaeIII enzymes in a 20 µl reaction volume, following the supplier's specifications (New England Biolabs, USA). Digested DNA was electrophoresed on a 20 cm long 1.5% agarose gel in 0.5 x Tris/borate/EDTA buffer (pH 8.2). The DNA was transferred onto the nylon membrane (Southern, 1975Go) and UV fixed using Strata linker (Stratagene, San Diego, USA), and the blots were hybridized with oligoprobe OAT20Y as mentioned earlier (Gauri Bala et al., 1996Go). The OAT20Y probe uncovered a 3.4 kb band representing the Yqh region of the human Y chromosome.

Chromosome analyses and estimation of hormonal levels
Wherever possible, chromosome analyses of the patients were conducted following standard protocols (Gauri Bala et al., 1996Go). However, due to logistic constraints, karyotype analyses of several cases could not be done. For assessing hormonal profiles, 100 µl of serum from each sample was used to estimate E2, LH, TSH, PRL and FSH levels by radioimmunoassay using commercial kits purchased from Bhabha Atomic Research Center, Bombay and Immuno Corp., Canada following the supplier's specifications

Fluorescence in-situ hybridization (FISH)
In an independent study, a blood sample from an aborted fetus (not listed in Table II) was used for chromosome preparation and for analysing the presence/absence of the Y chromosome using FISH. Metaphase chromosomes were prepared following standard methods (Gauri Bala et al., 1996Go). FISH was conducted with a labelled DYZ1 cloned probe using a Nick Translation Kit from Vysis (Illinois, USA). Hybridization, washing, counterstaining and mounting of the slides with DAPI were conducted following established protocols (Rahman et al., 2004Go). The slides were screened under the Olympus fluorescence microscope (BX 51) fitted with a vertical fluorescence illuminator U-LH100HG UV, excitation and barrier filters. Metaphase images were captured with a CCD camera and chromosomes were karyotyped using CytoVision 2.81 software from Applied Imaging Systems.


View this table:
[in this window]
[in a new window]
 
Table II. Details of the clinical, chromosomal and hormonal profiles of patients

 
Mutational analysis of the SRY gene
Mutational status of the SRY gene in patients was assessed by PCR, followed by cloning and sequencing of the resultant amplicons. In order to ascertain the authenticity of the mutations detected in other phenotypic females, the SRY sequences from four normal males, amplified by PCR, were cloned and sequenced. In addition, PCR products were also used for direct sequencing. The SRY sequences from four normal males (accession nos. AY601852, AY601853, AY601854 and AY601855) and five phenotypic female patients (accession nos. AY601856, AY601857, AY601858, AY601859 and AY601860) were deposited with GenBank. The patients' DNA sequences were subjected to multiple alignments with normal DNA (accession no. X53772) downloaded from GenBank using the CLUSTALW program on the default server (http://www.ebi.ac.uk/clustalw).


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Y chromosome variability in patients with genetic anomalies
Hormonal and chromosomal profiles of the patients studied were found to be abnormal in several cases compared to that of the normal ones (Table II). PCR-based analysis and Southern blot hybridization showed presence/absence of the Y-linked loci in several cases where the Y chromosome was not detectable cytogenetically. Of the 19 cases of TS analysed, 7 were found to be positive for SRY, 8 for PABY, 11 for DYZ3, 9 for DYS1 and 7 for DYZ1 loci. Interestingly, of all the cases of TS, only 5 samples were positive for all 5 loci, whereas, 7 were found to be negative. Thus, the majority of the patients with TS showed varying levels of aberrant Y chromosome. One sample (P60199bl) representing oligozoospermia was found to be positive for all the 5 loci. The number of patients belonging to different categories of genetic anomalies/syndrome and positive/negative status of different Y-linked loci therein are given in Table III. The amplicons from the representative patient samples corresponding to the SRY, PABY, DYZ3 and DYS1 loci are shown in Figure 1. The patients' samples positive for the DYZ1, based on Southern blot hybridization, are shown in Figure 2. Of those patients belonging to other categories, one phenotypic male (P7797) suffering from cryptorchidism was found to be negative for the SRY sequence. On the other hand, five phenotypic female patients (P2A/2, P21, P65971, P6697 and P20) were positive for the SRY gene.


View this table:
[in this window]
[in a new window]
 
Table III. Status of Y-linked loci in patients with sex chromosome-related anomalies

 


View larger version (24K):
[in this window]
[in a new window]
 
Figure 1. A representative gel showing PCR amplification of patients' genomic DNA. Panels A, B, C and D represent SRY, PABY, DYZ3 and DYS1 specific amplicons of 231, 970, 120 and 710 base pairs, respectively. As given in Table I, SRY primers RG4 and RG7 generating a 231 base-pair band were used for screening all the samples. The other set of primers, specific for SRY encompassing HMG box were used for the amplification of genomic DNA from the phenotypic female patients (data not shown). DNA from normal individuals of both the sexes was used as control and {Phi}X174/HaeIII DNA (M) as molecular size marker. Of the 34 patients whose DNA were analysed, results of only 10 samples are shown here. The remaining ones have been included in the diagrammatic illustration of Figure 7.

 


View larger version (43K):
[in this window]
[in a new window]
 
Figure 2. Typing of HaeIII digested genomic DNA of 27 patients with OAT20Y probe representing DYZ1 locus that shows a 3.4 kb band in the normal males. The remaining seven samples analysed independently, not shown here, have been included in the diagrammatic illustration of Figure 7. Note the presence of a male-specific 3.4 kb band in the patients. {lambda}\HindIII DNA was used as the molecular size marker given in kb.

 
Of these patients P20, an XY female with Swyer syndrome, was positive for all the Y-linked loci. Sequence analysis of the SRY gene from this patient (accession no. AY601858), encompassing HMG box, showed transition and transversion mutations (Figure 3). These mutations are predicted to alter the spatial organization of the SRY protein (Figure 4) and may affect its function. In addition, CLUSTALW multiple sequence alignment (www.ebi.ac.uk/clustalw) showed mutations in the 3' region at nucleotide positions 507 and 564, in patient P20, where G was changed to C and A to T, respectively. However, these mutations did not alter the amino acid sequences. Besides these changes, two deletions were detected at nucleotide positions 567 and 577 involving C at both positions. In a phenotypic female patient, P2A/2, multiple sequence alignment with CLUSTALW showed point mutation in the extreme 5' region of the SRY gene at position 1 changing nucleotide A to T in the start codon. This caused a change in the amino acid from methionine to leucine. Thus, of the five phenotypic females, three (P21, P65971 and P6697) showed normal SRY sequences, whereas two (P2A/2 and P20) showed mutations in the SRY gene. The result of CLUSTALW alignment of the SRY sequences from these patients and normal individuals is given in Figure 5.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. Schematic representation of the novel mutations detected in the SRY gene in a patient (P20). Positions of the mutations are marked with arrows in the 5' non-HMG box region (a: upper panel). The lower panel (b), shows the sequences (partial) from a normal and a mutant SRY gene. Mutations in the patient at nucleotide 46, 61 and 62 are underlined.

 


View larger version (25K):
[in this window]
[in a new window]
 
Figure 4. Predicted secondary structure of the SRY peptide encompassing the mutated region using default server (http://dot.imgen.bcm.tmc.edu:9331/seq-search/struc-predict.html). Normal peptide sequences (partial) and mutated ones in the 5' non-HMG box region at codons 16 and 21 are marked by an asterisk (*). An arrow shows a small helix in the normal SRY peptide, which is absent in the mutated one.

 


View larger version (50K):
[in this window]
[in a new window]
 
Figure 5. CLUSTALW (1.81) multiple alignment of subset sequences of the SRY gene from four normal males and five phenotypic female patients. Note the normal SRY sequence in all the males and indels in P20. The patient P2A/2 showed point mutation at the 5' position of the SRY gene resulting in a change in the start codon from methionine to leucine.

 
FISH analysis of an aborted fetus in an independent study (not listed in the Table II) showed complete absence of DYZ1 signal in some cells and varying levels of this signal in others (Figure 6a) portraying a gross level of Y chromosome mosaicism. Several metaphases from the normal males used as control showed discernible DYZ1-specific signals in the Yqh region of the Y chromosome(s) (Figure 6b). The DYZ1 signals on the long arm of the Y chromosome in normal males were clearly noticeable within the expected range (Figure 6b, C-I) compared to those in the cells devoid of such a signal from the aborted fetus (see Figure 6a). Thus, the present study establishes a correlation between the varying levels of the Y chromosome mosaicism uncovered by the presence/absence of the DYZ1 specific signals and RSA.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 6a. FISH using DYZ1 probe with metaphase chromosomes (A) and interphase nuclei (B, C, D, E and F) from the blood sample of an aborted fetus (not listed in Table II). A shows signal in the qh region of the Y chromosome; B, miniscule signal; C and D, complete absence of signal and E and F, detectable but reduced levels of signal compared to that of the normal Y chromosome.Figure 6b. A comparative profile of DYZ1 signals detected by FISH in metaphase chromosomes (A) and interphase nuclei (B) of the aborted fetus and Y chromosomes from several unrelated normal males (C–I). Note the signal variation within the Y chromosomes amongst different individuals.

 
Of all the samples analysed (Table II), the patients positive for the PABY locus were 64.7%; the SRY, 52.9%; the DYZ3, 73.5%; the DYS1, 64.7%; and for the DYZ1, 55.9%. However, in cases of TS, the patients positive for PABY were 42.1%; SRY, 36.84%; DYZ3, 57.9%; DYS1, 47.4%; and DYZ1, 36.8%. Interestingly, in both the categories, maximum numbers of samples were found to be positive for the DYZ3 locus. Presence/absence of the Y chromosome-linked loci in patients with their corresponding phenotypic sex is shown in a schematic illustration (Figure 7). The filled blocks correspond to the presence of the loci, whereas the empty ones denote their absence.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 7. Diagrammatic illustration highlighting the screening results of the patients' DNA with five Y chromosome-linked loci (PABY, SRY, DYZ3, DYS1 and DYZ1) used as markers. The filled blocks denote presence of the loci, whereas the empty ones correspond to absence of the same loci. Several phenotypic females, positive for one or more of these markers, suggest that low levels of Y chromosome mosaicism are common in the patients with sex chromosome anomalies.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
This study was undertaken with a view to ascertain loss or gain of five well-defined Y chromosome-linked loci in patients suffering from sex chromosome-related anomalies. Several phenotypic female patients were found to be positive for one or more of the Y-linked loci. This suggests that Y chromosome mosaicism is not uncommon, though the cause or the effect of such aberration remains unclear. Patients with genetic anomalies showed an abnormal hormonal profile indicating possible involvement of the autosomal genes in the diseased phenotype. This opens up newer vistas for the in-depth analysis of the candidate genes related to paracrine systems.

Mutations in the SRY gene
Mutations in the SRY gene have been reported in about 20% of the cases with XY gonadal dysgenesis. In the present study, mutations causing substitution of amino acids at codons 16 (Asp->Tyr) and 21 (Val->Pro) in the SRY gene result in the loss of a small helix prior to the HMG box in the 5' region (Figure 4). This altered conformation may affect the spatial organization of the SRY protein, rendering it incapable of functioning accurately as a transcription factor, as demonstrated by the predicted secondary structure analysis. Mutations in the SRY gene in Swyer syndrome have been reported to be involved in the sex reversal of the patient. Subject P20 appears to belong to this category substantiating that mutation(s) in the SRY gene could be a prime cause for sex reversal.

A phenotypic male patient (P7797) with cryptorchidism and hypogonadism positive for the four loci (PABY, DYZ3, DYS1 and DYZ1) was found to be negative for the SRY gene. The resultant phenotype could either be caused by the apparent deletion of the SRY gene or mutation(s) in some other genes. The patient (P19) suffering from male pseudohermaphroditism (positive for all the Y loci studied), seemed to have a structurally intact Y chromosome as revealed by DNA analysis, but the same was undetectable cytogenetically. Like other instances, this could also be a case of acute mosaicism with only fewer cells having a Y chromosome that escaped detection during cytogenetic analysis. A phenotypically male patient (P60199) suffering from oligozoospermia was also found to be positive for all the five loci, indicating the presence of an intact Y chromosome. However, on the basis of screening of a single sample, it is difficult to establish a correlation between presence/absence of these loci and oligozoospermia. In addition, mutation(s) in autosomal genes responsible for such an anomaly may not be ruled out. In a phenotypic female patient with Swyer syndrome (PRK137) and another with XXY syndrome (P21), the SRY gene was apparently intact since no mutation was detected. Nonetheless, mutation(s) in the flanking regions of the SRY gene leading to its ectopic expression or silencing of this gene may not be ruled out as reported earlier (Kwok et al., 1996Go; Poulat et al., 1997Go; Vietia et al., 1997Go). A phenotypic female proband (P060500MSF) suffering from RSA (Figure 7) was found to be positive for the PABY locus. In the absence of other causes, it is tempting to construe that this region may be responsible for abnormal exchange during zygotic cell divisions, leading to mitotic instability and eventually the loss of fetus. However, in the absence of direct evidence, no such conclusion can be drawn. These observations at best provide indirect evidence that in phenotypic females, presence of one or more Y-linked loci may be the cause of genetic anomalies, though involvement of autosomal genes may not be ruled out.

Y chromosome mosaicism and Turner syndrome
Turner patients with Y chromosomes have 15–20% increased risk of developing gonadoblastoma (Verp and Simpson, 1987Go) but the actual percentage of Y chromosome-bearing cells in the neoplastic tissue remains unclear. Thus, the assessment of the extent of the Y chromosome mosaicism in the infertile or subfertile cases is of relevance. In this context, we used DYZ1 repeat fraction as probe for FISH and its core sequences for DNA typing. The high copy number of DYZ1 (2000–4000 copies per Y chromosome) facilitated the detection of the Y chromosome even in the aberrant forms as shown in our FISH study (Figure 6a). Cryptic mosaicism of the Y chromosome has been reported to be a rare event and may be less than 1% (Medlej et al., 1992Go; Larsen et al., 1995Go; Jacobs et al., 1997Go; Yorifugi et al., 1997Go). In our study, Y chromosome mosaicism in Turner cases was found to be about 57%, which is apparently much higher than those reported from US and European populations. In the absence of sufficient data from other parts of India, no conclusion can be drawn. However, these observations are envisaged to be of great relevance in the context of future studies along these lines.

DYZ1 locus and its (in)stability
A putative role of DYZ1-related sequences for the development of normal males has been postulated (Lau and Schonberg, 1984Go; Manz et al., 1992Go). Typing of the patients' genomic DNA with a DYZ1 probe showed an allelic profile similar to that of normal males in more than 50% of cases (Figure 2). However, this typing system does not demonstrate loss or gain of the DYZ1 arrays resulting in copy number variation. FISH uncovers this copy number variation as demonstrated in a sample of RSA in the present study (Figure 6a). We hypothesize that a critical number of DYZ1 copies on the long arm of the human Y chromosome may be necessary for the maintenance of its structural and functional integrity. It has been argued that individuals with loss of almost all (or all) of the heterochromatin have normal male phenotypes. While this may be true, not all such males may be genetically fertile since the deletion of heterochromatin from the Yqh region, at times, may include neighbouring functional gene(s) as well. Analysis of such males for copy number variation of the DYZ1 fraction and assessment of their fertility status would prove to be informative. In the present study (see FISH data in Figure 6a and b), fewer copies of DYZ1 arrays in some cells and near normal ones in others from RSA may be a true reflection of its still uncharacterized biological significance.

Concluding remarks
Our work shows high levels of Y chromosome mosaicism in Turner cases. For the first time, a wide spectrum of Y chromosome aberrations, encompassing partial loss of DYZ1 fraction to its complete absence was noticed. Further, in several phenotypic females, presence or absence of one or more of the Y-linked loci were observed. Of all the Y-linked loci studied, DYZ3 was found to be present in the maximum number of cases, suggesting its more stable nature and important biological roles. In addition, acute organizational variation within the DYZ1 arrays is correlated with RSA. Irrespective of its biological significance, DYZ1 repeat fraction may be used as a probe to address a number of biological, clinical and forensic issues.


    Acknowledgements
 
We thank Dr Dinkar Sahal for critical review of the manuscript and Shri Khem Singh Negi for technical assistance. The work was supported by DBT grant no. BT/PR2225/Med/13/077/2000 and DST grant no. SP/SO/DO3/99 to SA and a core grant from the Department of Biotechnology, Government of India to the National Institute of Immunology, New Delhi. Equipment donation from the Alexander Von Humboldt Foundation, Bonn, Germany is gratefully acknowledged.


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Ali S, Muller CR and Epplen JT (1986) DNA fingerprinting by oligonucleotide probes specific for simple repeats. Hum Genet 74, 239–243.[Web of Science][Medline]

Bashamboo A, Bhatnagar S, Kaur A, Sarhadi VK, Singh JR and Ali S (2003) Molecular characterization of a Y-derived marker chromosome and identification of indels in the DYS1 region in a patient with stigmata of Turner syndrome. Curr Sci 84, 219–224.

Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN and Fellous M (1990) Genetic evidence equating SRY and the testis-determining factor. Nature 348, 448–450.[CrossRef][Medline]

Disteche CM, Casanova M, Saal H, Friedman C, Sybert V, Graham J, Thuline H, Page DC and Fellous M (1986) Small deletions of the short arm of the Y chromosome in 46, XY females. Proc Natl Acad Sci USA 83, 7841–7844.[Abstract/Free Full Text]

Fryns JP, Kleczkowska A, Kubien E and Van den BH (1995) XYY syndrome and other Y chromosome polysomies. Mental status and psychosocial functioning. Genet Couns 6, 197–206.[Web of Science][Medline]

Gauri Bala S, Ahmad J and Ali S (1996) Genomic distribution of 5'TTCCA3' repeat motif and its diagnostic potential in human Y-chromosome-related anomalies. Clin Genet 50, 358–365.[Web of Science][Medline]

Griffiths R and Tiwari B (1993) Primers for the differential amplification of the sex-determining region Y gene in a range of mammal species. Mol Ecol 2, 405–406.[Medline]

Hook EB and Warburton D (1983) The distribution of chromosomal genotypes associated with Turner's syndrome, live birth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 64, 24–27.[CrossRef][Web of Science][Medline]

Jacobs P, Dalton P, James R, Mosse K, Power M, Robinson D and Skuse D (1997) Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet 61, 471–483.[CrossRef][Web of Science][Medline]

Jager RJ, Anvret M, Hall K and Scherer G (1990) A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 348, 452–454.[CrossRef][Medline]

Joseph M, Cantu ES, Pai GS, Willi SM, Papenhausen PR and Weiss L (1996) Xp pseudoautosomal gene haploinsufficiency and linear growth deficiency in three girls with chromosome Xp22; Yq11 translocation. J Med Genet 33, 906–911.[Abstract/Free Full Text]

Kuroda-Kawaguchi T, Skaletsky H, Brown LG, Minx PJ, Cordum HS, Waterston RH, Wilson RK, Silber S, Oates R, Rozen S et al. (2001) The AZFc region on the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 29, 279–286.[CrossRef][Web of Science][Medline]

Kwok C, Tyler-Smith C, Mendonca BB, Hughes I, Berkovitz GD, Goodfellow PN and Hawkins JR (1996) Mutation analysis of the 2 kb 5' to SRY in XY females and XY intersex subjects. J Med Genet 33, 465–468.[Abstract/Free Full Text]

Lahn BT and Page DC (1997) Functional coherence of the human Y chromosome. Science 278, 675–680.[Abstract/Free Full Text]

Larsen T, Gravholt CH, Tillebeck A, Larsen H, Jensen MB and Freidrich U (1995) Parental origin of the X chromosome, X chromosome mosaicism and screening for "hidden" Y chromosome in 45, X Turner syndrome ascertained cytogenetically. Clin Genet 48, 6–11.[Web of Science][Medline]

Lau YF and Schonberg S (1984) A male-specific DNA probe detects heterochromatin sequences in a familial Yq-chromosome. Am J Hum Genet 36, 1394–1396.[Web of Science][Medline]

Manz E, Alkan M, Buhler E and Schmidtke J (1992) Arrangement of DYZ1 and DYZ2 repeats on the human Y-chromosome: a case with presence of DYZ1 and absence of DYZ2. Mol Cell Probes 6, 257–259.[CrossRef][Web of Science][Medline]

Medlej R, Lobaccaro JM, Berta P, Belon C, Leheup B, Toublanc JE, Weill J, Chevalier C, Dumas R and Sultan C (1992) Screening for Y-derived sex determining gene SRY in 40 patients with Turner syndrome. J Clin Endocrinol Metab 75, 1289–1292.[Abstract]

Nagafuchi S, Seki S, Nakahori Y, Tamura T, Numabe H and Nakagome Y (1992) PCR detection of structurally abnormal Y-chromosomes. Jpn J Hum Genet 37, 187–193.[CrossRef][Medline]

Ogata T and Matsuo N (1995) Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 95, 607–629.[Web of Science][Medline]

Ogata T, Yoshizawa A, Muroya K, Matsuo N, Fukushima Y, Rappold G and Yokoya S (1995) Short stature in a girl with partial monosomy of the pseudoautosomal region distal to DXYS15, further evidence for the assignment of the critical region for a pseudoautosomal growth gene(s). J Med Genet 32, 831–834.[Abstract/Free Full Text]

Page DC (2004) 2003 Curt Stern Award address. On low expectation exceeded; or, the genomic salvation of the Y chromosome. Am J Hum Genet 74, 399–402.[CrossRef][Web of Science][Medline]

Poulat F, Barbara PS, Desclozeaux M, Soullier S, Moniot B, Bonneaud N, Boizet B and Berta P (1997) The human testis-determining factor SRY binds a nuclear factor containing PDZ protein interaction domains. J Biol Chem 272, 7167–7172.[Abstract/Free Full Text]

Rahman MM, Bashamboo A, Prasad A, Pathak D and Ali S (2004) Organizational variation of DYZ1 repeat sequences on the human y chromosome and its diagnostic potentials. DNA Cell Biol 23, 561–571.[CrossRef][Web of Science][Medline]

Saxena R, Brown LG, Hawkins T, Alagappan RK, Skaletsky H, Reeve MP, Reijo R, Rozen S, Dinulos MB, Disteche CM et al. (1996) The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned. Nat Genet 14, 292–299.[CrossRef][Web of Science][Medline]

Schwinger E, Kirschstein M, Greiwe M, Konermann T, Orth U and Gal A (1996) Short stature in a mother and daughter with terminal deletion of Xp22.3. Am J Med Genet 63, 239–242.[CrossRef][Web of Science][Medline]

Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, Repping S, Pyntikova T, Ali J, Bieri T et al. (2003) The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423, 825–837.[CrossRef][Medline]

Southern EM (1975) Detection of species-specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98, 503–517.[CrossRef][Web of Science][Medline]

Spranger S, Kirsch S, Mertz A, Schiebel K, Tariverdian G and Rappold GA (1997) Molecular studies of an X;Y translocation chromosome in a woman with deletion of the pseudoautosomal region but normal height. Clin Genet 51, 346–350.[Web of Science][Medline]

Tilford CA, Kuroda-Kawaguchi T, Skaletsky H, Rozen S, Brown LG, Rosenberg M, McPherson JD, Wylie K, Sekhon M, Kukaba TA et al. (2001) A physical map of the human Y chromosome. Nature 409, 943–945.[CrossRef][Medline]

Verp MS and Simpson JL (1987) Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 25, 191–218.[CrossRef][Web of Science][Medline]

Vietia R, Ion A, Barbaux S, Jobling MA, Souleyreau N, Ennis K, Ostrer H, Tosi M, Meo T, Chibani J et al. (1997) Mutations and sequence variants in the testis-determining region of the Y chromosome in individuals with a 46, XY female phenotype. Hum Genet 99, 648–652.[CrossRef][Web of Science][Medline]

Yorifugi T, Muroi J, Kawai M, Sasaki H, Momoi T and Furusho K (1997) PCR-based detection of mosaicism in Turner syndrome patients. Hum Genet 99, 62–65.[CrossRef][Web of Science][Medline]

Submitted on August 25, 2004; resubmitted on October 28, 2004; accepted on November 9, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
A. Bashamboo, A. H. Taylor, K. Samuel, J.-J. Panthier, A. D. Whetton, and L. M. Forrester
The survival of differentiating embryonic stem cells is dependent on the SCF-KIT pathway
J. Cell Sci., August 1, 2006; 119(15): 3039 - 3046.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Premi, J. Srivastava, S. P. Chandy, J. Ahmad, and S. Ali
Tandem duplication and copy number polymorphism of the SRY gene in patients with sex chromosome anomalies and males exposed to natural background radiation
Mol. Hum. Reprod., February 1, 2006; 12(2): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
DNA ResHome page
D. Pathak, S. Premi, J. Srivastava, S. P. Chandy, and S. Ali
Genomic Instability of the DYZ1 Repeat in Patients with Y Chromosome Anomalies and Males Exposed to Natural Background Radiation
DNA Res, January 1, 2006; 13(3): 103 - 109.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
11/2/117    most recent
gah135v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bashamboo, A.
Right arrow Articles by Ali, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashamboo, A.
Right arrow Articles by Ali, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?